image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Mayborn - Gain to date: 247%

October 2004

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • MBY
Storming results from Mayborn have yet again led to broker, Baird, upgrading its forecasts, with pretax profit now expected to be £8.5m, for earnings of  28.1p (up from £8m and 26p) this year, rising to £9.1m and 29.3p next year. For the six months ended 30 June, turnover increased 10% to £32.2m, with pretax profit up 42% to £4.1m, while earnings rose a higher still 58% to 13.6p, helped by share buybacks.  Once again, the sparkling performer was the babycare division, which saw a 12% rise in turnover, driven by Sangenic (+21%) and Tommee Tippee (+18%). Margins also rose from 12.7% to 15.7%.  The potential competitive threat posed by new entrant, Neat, owned by Safety1st, has so far proved a ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X